MADISON, N.J., Aug. 13, 2015 – Merck Animal Health recently announced the winner of its Rely on REVALOR® (trenbolone acetate and estradiol) challenge – a contest that seeks to identify the best implant crew in the country while underscoring the importance of proper implanting techniques and their impact on cattle performance. Cattle Care Processing of Garden City, Kan., was named champion during the Cattle Feeders Business Summit. Crew members – Gayle Jackson, Oscar Escobedo, Katie Deal, Clifford Lightcap, Neely Hickman and Avrey Leon – received custom hats by Greeley Hat Works for taking the top honor.
“Training and monitoring are paramount to successful implanting. Cattle Care Processing is diligent about this, so it’s not surprising their crew had the highest percentage of properly placed implants,” said John Hutcheson, Ph.D., director of technical services, Merck Animal Health. “Overall within the industry, we saw 97.6 percent good implants checked compared to 95.6 percent in 2013, so we are continually seeing improvement in implant proficiency.”
Stampede Feeders is one of several feedyards that utilize the Cattle Care Processing crew for their implant needs. The 10,000- head capacity, 95 percent customer-owned feedyard is located in Scott City, Kan., and is committed to providing quality care and helping its customers maximize profits.
“We know the value of properly placed implants, and Cattle Care Processing always strives for 100 percent,” said Jerry Jackson, manager at Stampede Feeders. “Their experience, expertise and diligence, combined with Merck Animal Health’s support of training and regular checks, are second to none.”
Participants in the contest had to record at least 10 implant checks during the contest period. Of the 669 cattle checked at Stampede Feeders, 99.4 percent were good.
“When crews pay close attention to details and use proper techniques, they typically see a significant improvement in the number of good implants placed,” said Dr. Hutcheson. “Missing implants can cost producers up to 90 pounds in carcass weight, so taking the time to use proper procedures and check implants is definitely worth it.”
Dr. Hutcheson said because of the enthusiasm and participation we saw this past year, Merck Animal Health will host the contest again. To learn more and enroll an implant processing crew, contact your Merck Animal Health representative. To learn more about proper implanting, watch an instructional video at the Merck Animal Health Responsible Beef website – http://responsiblebeef.com/story/responsible-beef-stories-revalor-video.
About Merck Animal Health
Today’s Merck is a global healthcare leader working to help the world be well. Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global animal health business unit of Merck. Through its commitment to the Science of Healthier Animals™, Merck Animal Health offers veterinarians, farmers, pet owners and governments one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.merck-animal-health.com or connect with us on LinkedIn and Twitter at @MerckAH.
Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA
This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize,actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2014 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).